Form 4: XOMA CLO Granted 23,450 Performance Stock Units

XOMA Royalty Corp's Chief Legal Officer, Maricel Perea Montano, was granted 23,450 Performance Stock Units vesting upon the company's stock achieving a specified price.

Summary

• Maricel Perea Montano, Chief Legal Officer of XOMA Royalty Corp, was granted 23,450 Performance Stock Units (PSUs).
• The grant date for these PSUs was August 12, 2025.
• Each PSU represents a contingent right to receive one share of XOMA common stock.
• The PSUs vest upon XOMA's common stock achieving a specified price per share.
• The expiration date for these PSUs is May 16, 2026.
• Following this transaction, Maricel Perea Montano beneficially owns 23,450 derivative securities directly.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a routine compensation event, it signifies management's continued alignment with shareholder interests through performance-based incentives, which is generally viewed favorably.

Positives

• The grant of Performance Stock Units aligns the Chief Legal Officer's incentives directly with shareholder value creation, as vesting is contingent on the company's stock achieving a specified price.
• This compensation structure serves as a retention mechanism for a key executive, encouraging long-term commitment to the company's performance.

Negatives

• The PSUs have no immediate cash value and their ultimate value is contingent on future stock performance, introducing uncertainty for the recipient.
• The conversion of PSUs into common stock could lead to a minor dilutive effect on existing shares, although the amount is relatively small.

Risks

• The primary risk is that the company's common stock may not achieve the specified price per share required for the PSUs to vest, resulting in the forfeiture of the units.
• Market volatility and broader economic conditions could negatively impact the stock price, preventing the vesting conditions from being met.

Future Outlook

The vesting condition of the Performance Stock Units, tied to XOMA's common stock achieving a specified price per share, indicates a forward-looking expectation for stock price appreciation and performance.

Industry Context

The grant of Performance Stock Units is a common practice in the biotechnology and royalty acquisition sectors for executive compensation. This method is widely used to incentivize long-term performance and align management interests with shareholder returns, particularly in companies where stock performance is a key indicator of success.

Comparison to Industry Standards

• Performance Stock Units (PSUs) are a standard component of long-term incentive plans for executives across various industries, including biotech and pharmaceutical royalty companies.
• The use of stock price targets for vesting is a common mechanism to ensure that executive compensation is directly linked to the creation of shareholder value, similar to practices observed at companies like Royalty Pharma plc or BioNTech SE, which also utilize performance-based equity awards.
• The grant of 23,450 PSUs to a Chief Legal Officer is within the typical range for executive compensation packages in companies of similar market capitalization and operational scope, though specific targets vary by company strategy and market conditions.

Related Party Transactions

• The grant of Performance Stock Units to Maricel Perea Montano, the Chief Legal Officer, constitutes a related party transaction as it involves compensation to a key management personnel.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value if the stock price targets are met, as management is incentivized to achieve these goals. Minor potential for dilution upon conversion of PSUs.
• Employees: No direct impact on general employees, but it reinforces the company's compensation philosophy for executives.
• Management: The Chief Legal Officer is directly incentivized to contribute to the company's stock performance, aligning personal financial interests with corporate success.

Next Steps

• The company's common stock will need to achieve a specified price per share for the granted Performance Stock Units to vest.
• The PSUs will expire on May 16, 2026, if vesting conditions are not met by then.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation grant and does not contain new material information that would fundamentally alter the investment thesis for XOMA Royalty Corp. While the grant aligns management incentives with shareholder value, it is a standard practice and does not warrant a change in investment recommendation based solely on this disclosure.

Keywords

XOMA, Performance Stock Units, PSU, Executive Compensation, Stock Grant, SEC Form 4, Maricel Perea Montano, Chief Legal Officer